PGC1α is important for glutamine metabolism in ERBB2‐positive breast cancer (McGuirk et al., 2013) and glutamine transporters are proposed therapeutic targets in melanoma (Wang et al., 2014), highlighting the therapeutic potential of this metabolic pathway. Here, ERBB2 is linked to breast cancer.